NO991160L - Sulfaterte polysakkarider og anvendelser derav i medisinsk behandling - Google Patents

Sulfaterte polysakkarider og anvendelser derav i medisinsk behandling

Info

Publication number
NO991160L
NO991160L NO991160A NO991160A NO991160L NO 991160 L NO991160 L NO 991160L NO 991160 A NO991160 A NO 991160A NO 991160 A NO991160 A NO 991160A NO 991160 L NO991160 L NO 991160L
Authority
NO
Norway
Prior art keywords
applications
medical treatment
compounds
sulfated polysaccharides
compositions
Prior art date
Application number
NO991160A
Other languages
English (en)
Other versions
NO991160D0 (no
Inventor
Michael William Grady
Peter John Doyle
Laura Sinclair
Paul Houston
Original Assignee
Johnson & Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd
Publication of NO991160D0 publication Critical patent/NO991160D0/no
Publication of NO991160L publication Critical patent/NO991160L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Sulfaterte, oksyderte, regenererte celluloseforbindelser, sulfaterte alginater, og saltene og hydratene derav. Forbindelsene oppnås ved sulfatering av oksydert regenerert cellulose med svoveltrioksyd. Det tilveiebringes også farmasøytiske preparater omfattende for- bindelsene, spesielt preparater for behandling av medisinske tilstander formidlet av en matrise-metalloproteinase samt farmasøytiske antikoaguleringsmiddelpreparater.
NO991160A 1996-09-11 1999-03-10 Sulfaterte polysakkarider og anvendelser derav i medisinsk behandling NO991160L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9618958A GB2317182B (en) 1996-09-11 1996-09-11 Sulfated polysaccharides and uses thereof in medical treatment
PCT/GB1997/002477 WO1998011141A1 (en) 1996-09-11 1997-09-10 Sulfated polysaccharides and uses thereof in medical treatment

Publications (2)

Publication Number Publication Date
NO991160D0 NO991160D0 (no) 1999-03-10
NO991160L true NO991160L (no) 1999-05-10

Family

ID=10799755

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991160A NO991160L (no) 1996-09-11 1999-03-10 Sulfaterte polysakkarider og anvendelser derav i medisinsk behandling

Country Status (14)

Country Link
US (1) US20090227537A1 (no)
EP (1) EP0925310B1 (no)
JP (1) JP2001500184A (no)
KR (1) KR20000036061A (no)
AU (1) AU726555B2 (no)
BR (1) BR9711747A (no)
CA (1) CA2265780C (no)
DE (1) DE69702862T2 (no)
DK (1) DK0925310T3 (no)
ES (1) ES2152107T3 (no)
GB (1) GB2317182B (no)
NO (1) NO991160L (no)
PT (1) PT925310E (no)
WO (1) WO1998011141A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
AU3759100A (en) * 1999-03-24 2000-10-09 B.F. Goodrich Company, The Inhibition of matrix metalloproteinases with polymers and pharmaceutical applications thereof
DE10050870A1 (de) * 2000-10-11 2002-08-01 Knoell Hans Forschung Ev Biokompatibles Verbundmaterial für medizinische Anwendungen
US7988962B2 (en) 2003-12-02 2011-08-02 Universiteit Gent Use of polysulphated alginate in cellular matrices
DE102006024748A1 (de) * 2006-05-26 2007-11-29 Paul Hartmann Ag Proteasen-Inhibitor zur Wundbehandlung
DE102007035322B4 (de) 2007-07-25 2011-11-17 Friedrich-Schiller-Universität Jena Verfahren zur Herstellung wasserlöslicher, niedrig substituierter Cellulosesulfate
BRPI0909849A2 (pt) 2008-04-04 2015-10-06 Univ Utah Res Found éteres semi-sintéticos de glicosaminoglicosanos e métodos para fazê-los e usá-los
IT1397246B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
US9522162B2 (en) 2011-03-23 2016-12-20 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
EP2699626A4 (en) * 2011-04-11 2014-10-29 Univ Massachusetts Medical CHEMICALLY MODIFIED CELLULOSE FIBROUS MESH FOR USE AS TISSUE ENGINEERING SCAFFOLDING
CN103360499B (zh) * 2012-04-11 2017-02-08 厦门大学 一种纤维素硫酸酯的简便合成工艺
CN104277130A (zh) 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
WO2015177379A2 (en) 2014-05-23 2015-11-26 Reponex Pharmaceuticals Aps Compositions for promoting the healing of wounds
EP3848047A1 (en) 2014-07-24 2021-07-14 Reponex Pharmaceuticals APS Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
CN111228653A (zh) 2018-11-13 2020-06-05 格莱科米拉治疗公司 用电离辐射加强癌症治疗的方法
US11491199B1 (en) 2021-06-09 2022-11-08 King Abdulaziz University Anticoagulation activity of sulfated carboxymethyl cellulose/Azadirachta indica leaf powder-based biocomposites

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1056772A (fr) * 1950-06-23 1954-03-02 Procédé de préparation d'un anticoagulant de synthèse
US3115488A (en) * 1960-02-29 1963-12-24 American Home Prod Alginic acid methyl ester sulfates, preparation and molecular weight fractionation thereof
FR1730M (fr) * 1962-01-17 1963-03-18 Charles Riviere Nouvelle composition de collyre.
JPS4943937B1 (no) * 1970-12-28 1974-11-25
US3709877A (en) * 1972-03-07 1973-01-09 Johnson & Johnson Process for the sulfation of cellulosic ethers
US3804092A (en) * 1973-01-15 1974-04-16 Johnson & Johnson Water dispersible nonwoven fabric
JPS5152484A (en) * 1974-10-18 1976-05-10 Sumitomo Chemical Co Pururanno ryusanesuteru oyobi sono enruino seizohoho
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
GB2148901A (en) * 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules
JPH02178229A (ja) * 1988-12-28 1990-07-11 Fujirebio Inc 抗ウイルス剤
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5997863A (en) * 1994-07-08 1999-12-07 Ibex Technologies R And D, Inc. Attenuation of wound healing processes

Also Published As

Publication number Publication date
DE69702862D1 (de) 2000-09-21
GB2317182A (en) 1998-03-18
DE69702862T2 (de) 2001-02-22
JP2001500184A (ja) 2001-01-09
US20090227537A1 (en) 2009-09-10
CA2265780A1 (en) 1998-03-19
EP0925310A1 (en) 1999-06-30
AU726555B2 (en) 2000-11-09
PT925310E (pt) 2000-11-30
BR9711747A (pt) 1999-08-24
EP0925310B1 (en) 2000-08-16
AU4131597A (en) 1998-04-02
ES2152107T3 (es) 2001-01-16
KR20000036061A (ko) 2000-06-26
NO991160D0 (no) 1999-03-10
CA2265780C (en) 2006-08-22
DK0925310T3 (da) 2000-11-20
GB2317182B (en) 2000-11-01
WO1998011141A1 (en) 1998-03-19
GB9618958D0 (en) 1996-10-23

Similar Documents

Publication Publication Date Title
NO991160L (no) Sulfaterte polysakkarider og anvendelser derav i medisinsk behandling
BR7903564A (pt) Composicao aquosa de polimero,composicao espessante e processo para o espessamento de uma composicao aquosa
DE3785758D1 (de) Wundheilung und knochenregeneration.
ATE131176T1 (de) Sulfatierte polysaccharide, antikoagulierungs- und antikomplementärmittel, hergestellt aus fukanen aus braunen algen, und verfahren zu deren herstellung.
HUP9903404A2 (hu) Oxidált oligoszacharidok
DK0659440T3 (da) Calcium-modificeret, oxideret cellulose-hæmostat
NO900392L (no) Heparinderivater og fremgangsmaate til fremstilling derav.
DE3750899D1 (de) Polymer für Toner, dessen Herstellungsverfahren und Tonerzusammensetzung.
FR2358157A1 (fr) Oligosaccharides sulfates utiles notamment comme inhibiteurs du complement
PT92821A (pt) Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
PT734259E (pt) Utilizacao de derivados de piperidina para o tratamento da esquizofrenia
ATE6586T1 (de) Substituierte arylenverbindungen und deren herstellungsverfahren.
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
EA199900542A1 (ru) Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида
DE3485100D1 (de) Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
ES2054944T3 (es) Bis-(tri-t-alquilfenoxi) difosfaespiroundecanos.
DE69705110D1 (de) Topische pharmazeutische zusammensetzungen, welche heparin enthalten
IT1140396B (it) Agente promotore per la coagulazione del sangue
BR0012622A (pt) Derivados de 3-amino-2-benzil-1-fenil-propano
BR0010810A (pt) Compostos de ácido alfa-amino-beta-sulfonila
DE59106803D1 (de) Substituierte Pyrido-oxazine.
IT8323925A0 (it) Derivati bezilidenici solforati, loro preparazione e loro applicazione in terapia.
PT968174E (pt) 2-aminotetralina opticamente activa processo para a sua preparacao e composicoes farmaceuticas contendo a mesma activas na prevencao e tratamento do choque septico
IT1267497B1 (it) Polimero anionico, ad esempio di tipo superassorbente e relativo procedimento di produzione.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application